Documents

Q1 FY27 delivered robust revenue growth and stable margins, with expansion and innovation ongoing.

Forensic audit ordered by court does not impact operations or growth plans; compliance remains strong.

FY 2026 saw double-digit growth, margin expansion, and major capacity additions, with strong FY 2027 outlook.

Strong revenue and margin growth driven by expansion, digital channels, and acquisitions.

Q2 FY26 delivered double-digit revenue and EBITDA growth, margin gains, and strong expansion momentum.

Strong Q1 growth with margin expansion, network additions, and robust specialty performance.

Strong FY25 growth, margin expansion, and strategic investments set up robust FY26 prospects.

Strong Q3 growth, margin expansion, and focused brownfield expansion drive positive outlook.

Strong revenue and margin growth driven by hospitals, diagnostics, and expansion initiatives.